Today: 27 January 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Destiny Tech100 (DXYZ) Stock Surges on SpaceX IPO Buzz: What Happened This Week, Premium-to-NAV Reality Check, and Week-Ahead Watchlist (Updated Dec. 12, 2025)

Destiny Tech100 (DXYZ) Stock Surges on SpaceX IPO Buzz: What Happened This Week, Premium-to-NAV Reality Check, and Week-Ahead Watchlist (Updated Dec. 12, 2025)

Updated: Dec. 12, 2025 (U.S. market close). Destiny Tech100 Inc. (NYSE: DXYZ) just posted a sharp, high-volume run-up as investor attention snapped back to one theme: SpaceX IPO speculation—and what it could mean for public-market “access” vehicles tied to private tech leaders. But DXYZ isn’t a conventional operating company stock. It’s a closed-end management investment company built to hold a…
14 December 2025
···
Altria (MO) Stock This Week: CEO Succession, Dividend Update, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Altria (MO) Stock This Week: CEO Succession, Dividend Update, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Updated: December 12, 2025 (after market close) Altria Group, Inc. (NYSE: MO) ended the week on a quiet but steady note—closing at $58.75 on Friday, Dec. 12, extending a five-session grind higher from $58.11 on Dec. 8 (about +1.1% for the week). InvestingWhile the broader market sold off on Friday, Altria’s shares were essentially unchanged on the day—an example of…
14 December 2025
···
Milestone Pharmaceuticals (MIST) Stock Update: FDA Approves CARDAMYST (Etripamil) — This Week’s Volatility, Analyst Forecasts, and What to Watch Next (Updated Dec. 12, 2025)

Milestone Pharmaceuticals (MIST) Stock Update: FDA Approves CARDAMYST (Etripamil) — This Week’s Volatility, Analyst Forecasts, and What to Watch Next (Updated Dec. 12, 2025)

Updated: Friday, December 12, 2025 (U.S. market close) Milestone Pharmaceuticals Inc. (NASDAQ: MIST) closed out the week in the spotlight after the company announced U.S. FDA approval of CARDAMYST™ (etripamil)—positioning Milestone to transition from a development-stage biotech to a commercial-stage cardiovascular company. GlobeNewswire The stock action was anything but calm. MIST closed at $2.41 on Dec. 12, down 18.31%, after…
14 December 2025
····
MercadoLibre Stock (NASDAQ: MELI) Weekly Update and Week-Ahead Outlook: Humanoid Robots Deal, $750M Notes, and Key Levels to Watch (Updated Dec. 12, 2025)

MercadoLibre Stock (NASDAQ: MELI) Weekly Update and Week-Ahead Outlook: Humanoid Robots Deal, $750M Notes, and Key Levels to Watch (Updated Dec. 12, 2025)

Updated: December 12, 2025 (U.S. market close)Meta description: MercadoLibre (MELI) ended the week near $2,016 after a volatile stretch that included a 5% midweek drop, a new humanoid-robot warehouse pilot, and a $750 million bond deal. Here’s what moved the stock this week and what investors are watching next week. MercadoLibre, Inc. (NASDAQ: MELI) closed Friday, Dec. 12, 2025 at…
14 December 2025
···
AbbVie Stock Outlook (ABBV): Weekly Recap, Fresh Analyst Upgrades, and the Week-Ahead Setup (Updated Dec. 12, 2025)

AbbVie Stock Outlook (ABBV): Weekly Recap, Fresh Analyst Upgrades, and the Week-Ahead Setup (Updated Dec. 12, 2025)

AbbVie Inc. (NYSE: ABBV) ended the week of Dec. 8–12, 2025 near $223, after a choppy stretch that featured two notable Wall Street moves—an HSBC upgrade and a Morgan Stanley price-target hike—alongside ongoing headlines tied to AbbVie’s oncology and neuroscience pipeline. Yahoo Finance For investors, the near-term story remains a familiar one: ABBV’s share price is being pulled between defensive-dividend…
14 December 2025
···
Medical Properties Trust (MPW) Stock: This Week’s Slide, Tenant Headlines, Dividend Update, and What to Watch Next Week (Updated Dec. 12, 2025)

Medical Properties Trust (MPW) Stock: This Week’s Slide, Tenant Headlines, Dividend Update, and What to Watch Next Week (Updated Dec. 12, 2025)

Medical Properties Trust (NYSE: MPW) ended the week near $5.10 after a sharp Thursday drop. Here’s what moved MPW stock this week, the latest tenant and legal headlines, analyst forecasts, and the key catalysts to watch in the week ahead. Medical Properties Trust, Inc. (NYSE: MPW) finished the Dec. 8–12 trading week under renewed pressure, closing Friday around $5.10 after…
14 December 2025
····
NextEra Energy (NEE) Stock Update: AI Data Center Deals, Higher 2026 EPS Outlook, and What to Watch Next Week (Updated Dec. 12, 2025)

NextEra Energy (NEE) Stock Update: AI Data Center Deals, Higher 2026 EPS Outlook, and What to Watch Next Week (Updated Dec. 12, 2025)

NextEra Energy (NEE) closed at $81.65 on Dec. 12 after a headline-heavy week featuring new Google Cloud and Meta agreements, raised 2025–2026 EPS guidance, and fresh analyst price targets. NextEra Energy, Inc. (NYSE: NEE) ended Friday, Dec. 12, 2025, at $81.65. Yahoo Finance That close caps a volatile, news-packed week in which the company leaned hard into a single message…
14 December 2025
····
Coca-Cola Stock (KO) Outlook: CEO Transition, Dividend Week, Analyst Targets — Updated Dec. 12, 2025

Coca-Cola Stock (KO) Outlook: CEO Transition, Dividend Week, Analyst Targets — Updated Dec. 12, 2025

Updated: Friday, December 12, 2025 (U.S. market close)Company: The Coca-Cola Company (NYSE: KO) Coca-Cola stock ended the week near the $70 level after a choppy stretch of trading that included a sharp one-day dip and a strong Friday rebound. Investors are weighing a leadership transition set for 2026, the company’s steady “defensive” profile, and the next set of catalysts: a…
14 December 2025
····
Realty Income (NYSE: O) Stock This Week: Dividend Hike, $800M Las Vegas Deal, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Realty Income (NYSE: O) Stock This Week: Dividend Hike, $800M Las Vegas Deal, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Realty Income Corporation (NYSE: O) closed this week with investors balancing two fresh, shareholder-friendly headlines—a new dividend increase and a headline-grabbing $800 million preferred equity investment in CityCenter Las Vegas—against the bigger force that still tends to steer net-lease REITs: interest rates and bond yields. StockAnalysis Below is what moved Realty Income stock this week, what the latest announcements mean…
14 December 2025
····
DoorDash Stock Forecast (DASH): News, Catalysts, and Week-Ahead Outlook After Friday’s $227.49 Close (Updated Dec. 12, 2025)

DoorDash Stock Forecast (DASH): News, Catalysts, and Week-Ahead Outlook After Friday’s $227.49 Close (Updated Dec. 12, 2025)

Updated: December 12, 2025 — DoorDash, Inc. (NASDAQ: DASH) ended Friday at $227.49, up 1.32% on the day, with a market value of roughly $99.6 billion. FinanceCharts It was a volatile week for DoorDash stock: shares slid hard midweek as investors repriced the competitive outlook in online grocery and “instant” delivery, then stabilized as attention turned back to DoorDash’s scale,…
13 December 2025
···
Altria (MO) Stock Update: New Dividend, CEO Succession, and What to Watch Next Week (Updated Dec. 12, 2025)

Altria (MO) Stock Update: New Dividend, CEO Succession, and What to Watch Next Week (Updated Dec. 12, 2025)

Updated: December 12, 2025 Altria Group, Inc. (NYSE: MO) ended Friday, Dec. 12, at $58.75, extending a string of modest daily gains and leaving the stock up roughly ~1%–1.3% over the last five sessions—a steady week for a high-yield, defensive name as investors digested two company-specific headlines: a CEO succession announcement and a fresh quarterly dividend declaration. StockAnalysis With the…
13 December 2025
····
Nike Stock (NKE) This Week: Fed Rate Cut Fuels a Bounce as Earnings Loom — Latest News, Forecasts and Week-Ahead Setup (Updated Dec. 12, 2025)

Nike Stock (NKE) This Week: Fed Rate Cut Fuels a Bounce as Earnings Loom — Latest News, Forecasts and Week-Ahead Setup (Updated Dec. 12, 2025)

Updated: December 12, 2025 (U.S. market close) Nike, Inc. (NYSE: NKE) heads into next week with its biggest near-term catalyst on the calendar: fiscal Q2 2026 earnings on Thursday, Dec. 18 (after the close). Nike Investor Relations After a volatile start to the week, Nike shares finished Friday at $67.47 (down 0.40% on the day) and ended the week up…
13 December 2025
····
1 … 658 659 660 661 662 … 847

Stock Market Today

  • Jim Cramer Advises Patience on Starbucks Ahead of Earnings
    January 27, 2026, 1:39 PM EST. Jim Cramer highlighted Starbucks ahead of its Wednesday earnings report and Thursday investor day. After a strong 14.5% gain early in 2024, he downgraded the stock to a 2-rating, advising investors to be patient. Unless Starbucks delivers strong results, the stock could dip as CEO Brian Niccol is expected to outline a multi-year turnaround rather than immediate gains. Meanwhile, Tuesday's mixed market saw winners like Corning jump over 16% on a $6 billion Meta contract, while Procter & Gamble fell nearly 1% after a TD Cowen downgrade amid concerns about subdued U.S. growth. Upcoming earnings from Microsoft, Meta, and Apple weigh on investor sentiment as the Federal Reserve meeting looms.
Go toTop